Potential role of hypoxia imaging using 18F-FAZA PET to guide hypoxia-driven interventions (carbogen breathing or dose escalation) in radiation therapy

Radiotherapy and Oncology

Volumn 113, Issue 2, 2014, Pages 204-209

  Tran, Ly Binh An ^a   Bol, Anne ^a   Labar, Daniel ^a   Karroum, Oussama ^a   Bol, Vanesa ^a   Jordan, Bénédicte ^a   Grégoire, Vincent ^a   Gallez, Bernard ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

18F FAZA; Carbogen; Dose escalation; EPR; Hypoxia

Indexed keywords

2 NITROIMIDAZOLE; ARABINOSIDE; CARBOGEN; FLUORINE 18; FLUOROAZOMYCIN ARABINOSIDE F 18; UNCLASSIFIED DRUG; CARBON DIOXIDE; FLUOROAZOMYCIN ARABINOSIDE; NITROIMIDAZOLE DERIVATIVE; OXYGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RADIOTHERAPY; ELECTRON SPIN RESONANCE; GLIOMA; HYPOXIA; MALE; NONHUMAN; OXIMETRY; POSITRON EMISSION TOMOGRAPHY; RADIATION DOSE ESCALATION; RAT; RHABDOMYOSARCOMA; TUMOR GROWTH; TUMOR HYPOXIA; ANIMAL; CELL HYPOXIA; COMPUTER ASSISTED RADIOTHERAPY; DIAGNOSTIC IMAGING; DIAGNOSTIC USE; DISEASE MODEL; DRUG EFFECTS; FISCHER 344 RAT; METABOLISM; PHYSIOLOGY; PRESSURE; PROCEDURES; PROGNOSIS; RANDOMIZATION; SCINTISCANNING;

ANIMALS; CARBON DIOXIDE; CELL HYPOXIA; DIAGNOSTIC IMAGING; DISEASE MODELS, ANIMAL; GLIOMA; MALE; NITROIMIDAZOLES; OXIMETRY; OXYGEN; PARTIAL PRESSURE; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RANDOM ALLOCATION; RATS; RATS, INBRED F344; RHABDOMYOSARCOMA;

EID: 84915827714     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2014.09.016     Document Type: Article

References (31)

1. M. Nordsmark, S.M. Bentzen, and V. Rudat Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study Radiother Oncol 77 2005 18 24
2. L.H. Gray, A.D. Conger, M. Ebert, S. Hornsey, and O.C.A. Scott The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy Br J Radiol 26 1953 638 648
3. L.B. Harrison, M. Chadha, R.J. Hill, K. Hu, and D. Shasha Impact of tumor hypoxia and anemia on radiation therapy outcomes The Oncologist 7 2002 492 508
4. M.R. Horsman, B.G. Wouters, M.C. Joiner, and J. Overgaard The oxygen effect and fractionated radiotherapy M. Joiner, A. van der Kongel, Basic Clinical Radiobiology 4th ed. 2009 Edward Arnold London 207 216
5. J. Overgaard Hypoxic radiosensitization: adored and ignored J Clin Oncol 25 2007 4066 4074
6. M.R. Horsman, L.S. Mortensen, J.B. Petersen, M. Busk, and J. Overgaard Imaging hypoxia to improve radiotherapy outcome Nat Rev Clin Oncol 9 2012 674 687
7. I. Toma-Dasu, J. Uhrdin, L. Antonovic, A. Dasu, S. Nuyts, and P. Dirix Dose prescription and treatment planning based on FMISO-PET hypoxia Acta Oncol 51 2012 222 230
8. J. Overgaard, H.S. Hansen, M. Overgaard, L. Bastholt, A. Berthelsen, and L. Specht A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85 Radiother Oncol 46 1998 135 146
9. P. Danhier, C.J. De Saedeleer, O. Karroum, G. De Preter, P.E. Porporato, and B.F. Jordan Optimization of tumor radiotherapy with modulators of cell metabolism: toward clinical applications Semin Radiat Oncol 23 2013 262 272
10. C. Menon, and D.L. Fraker Tumor oxygenation status as a prognostic marker Cancer Lett 221 2005 225 235
11. G. Lucignani PET imaging with hypoxia tracers: a must in radiation therapy Eur J Nucl Med Mol Imaging 35 2008 838 842
12. M. Piert, H.-J. Machulla, and M. Picchio Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside J Nucl Med 46 2005 106 113
13. G. Reischl, D.S. Dorow, and C. Cullinane Imaging of tumor hypoxia with [124I] IAZA in comparison with [18F]FMISO and [18F]FAZA-first small animal PET results J Pharm Pharm Sci 10 2007 203 211
14. D. Sorger, M. Patt, and P. Kumar [18F]Fluoroazomycinarabinofuranoside (18FAZA) and [18F]Fluoromisonidazole (18FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors Nucl Med Biol 30 2003 317 326
15. G. Reischl, A. Sabbah, and H.J. Machulla [18F]FAZA and [18F]FMISO. In vitro comparison in hypoxic human tumor cells J Nucl Med 48 2007 325P
16. M. Busk, M.R. Horsman, and S. Jakobsen Can hypoxia-PET map hypoxic cell density heterogeneity accurately in an animal tumor model at a clinically obtainable image contrast? Radiother Oncol 92 2009 429 436
17. G.B. Halmos, L.B. De Bruin, J.A. Langendijk, B.F.A.M. Van der Laan, J. Pruim, and R.J.H.M. Steenbakkers Head and neck tumor hypoxia imaging by 18F-Fluoroazomycin-arabinoside (18F-FAZA)-PET: a review Clin Nucl Med 39 2014 44 48
18. L.-B.-A. Tran, A. Bol, and D. Labar Hypoxia imaging with the nitroimidazole 18F-FAZA PET tracer: a comparison with OxyLite, EPR oximetry and 19F-MRI relaxometry Radiother Oncol 105 2012 29 35
19. L.S. Mortensen, M. Busk, and M. Nordsmark Accessing radiation response using hypoxia PET imaging and oxygen sensitive electrodes: a preclinical study Radiother Oncol 99 2011 418 423
20. W. Landuyt, B. Ahmed, and S. Nuyts In vivo antitumor effect of vascular targeting combined with either ionizing radiation or anti-angiogenesis treatment Int J Radiat Oncol Biol Phys 49 2001 443 450
21. G. Reischl, W. Ehrlichmann, and C. Bieg Preparation of the hypoxia imaging PET tracer [18F]FAZA: reaction parameters and automation Appl Radiat Isot 62 2005 897 901
22. B.F. Jordan, C. Baudelet, and B. Gallez Carbon-centered radicals as oxygen sensors for in vivo electron paramagnetic resonance: screening for an optimal probe among commercially available charcoals Magn Reson Mater Phys, Biol Med 7 1998 121 129
23. L.M. Rodrigues, F.A. Howe, J.R. Griffiths, and S.P. Robinson Tumor R2 is a prognostic indicator of acute radiotherapeutic response in rodent tumors J Magn Reson Imaging 19 2004 482 488
24. B.F. Jordan, J. Magat, and F. Colliez Mapping of oxygen by imaging lipids relaxation enhancement: a potential sensitive endogenous MRI contrast to map variations in tissue oxygenation Magn Reson Med 70 2013 732 744
25. K.M. ∅vrebø, T. Hompland, B. Mathiesen, and E.K. Rofstad Assessment of hypoxia and radiation response in intramuscular experimental tumors by dynamic contrast-enhanced magnetic resonance imaging Radiother Oncol 102 2012 429 435
26. D. Zips, K. Zöphel, and N. Abolmaali Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer Radiother Oncol 105 2012 21 28
27. P. Mahy, M. De Bast, and B. Gallez In vivo colocalization of 2-nitroimidazole EF5 fluorescence intensity and electron paramagnetic resonance oximetry in mouse tumors Radiother Oncol 67 2003 53 61
28. C.M.L. Zegers, W. Van Elmpt, and R. Wierts Hypoxia imaging with [(18)F]HX4 PET in NSCLC patients: defining optimal imaging parameters Radiother Oncol 109 2013 58 64
29. 64Cu-ATSM positron emission tomography/computed tomography BMC Cancer 13 2013 218
30. B.F. Jordan, and B. Gallez Surrogate MR markers of response to chemo- or radiotherapy in association with co-treatments: a retrospective analysis of multi-modal studies Contrast Media Mol Imaging 5 2010 323 332
31. B. Gallez, C. Baudelet, and B.F. Jordan Assessment of tumor oxygenation by electron paramagnetic resonance: principles and applications NMR Biomed 17 2004 240 262